Dave Stewart named Chief Technology and Transformation Officer at Avid. Read the Release
Dave Stewart named Chief Technology and Transformation Officer at Avid. Read the Release
Division of Biochemical Technology of the American Chemical Society Annual Meeting
ASC BioT – 2025 Annual Conference
March 23, 2025 - March 27, 2025
Related Events
The newly created role marks a major step in CEO Kenneth Bilenberg’s vision to scale Avid for its next chapter of growth. TUSTIN, Calif., November 10, 2025 – Avid […]
Read moreTustin, CA, USA – September 15, 2025 – Avid Bioservices, Inc., a leading biologics contract development and manufacturing organization (CDMO), today announced the appointment of Kenneth Bilenberg as its new […]
Read moreSOUTH SAN FRANCISCO, California – August 05, 2025 – Privately held CHO Plus, Inc. announced today a project agreement awarded from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical […]
Read moreDownload PDF Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract Development and Manufacturing Organisation Avid Bioservices now completed GHO […]
Read moreDownload PDFAvid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger TUSTIN, Calif., February 5, 2025 — Avid […]
Read moreDownload PDFTUSTIN, Calif., Jan. 30, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve […]
Read more